Philip Clarke
Professor of Health Economics & Director, HERC
- Professor of Health Economics, University of Oxford
- Academic, Melbourne School of Population and Global Health
- Honorary, Melbourne Institute of Applied Economic and Social Research
Professor Philip Clarke re-joined HERC in August 2018 after previous appointments at the Universities of Sydney and Melbourne in Australia. He is a Fellow of the Academy of the Social Sciences in Australia (ASSA).
His research interests include developing methods to value the benefits of improving access to health care, health inequalities and the use of simulation models in health economic evaluation. Philip has been involved in the development of the UKPDS Outcomes Model, a health economic simulation model for type 2 diabetes.
Recent publications
-
Flash glucose monitoring for Indigenous Australians with type 2 diabetes: a randomised pilot and feasibility study
Eer AS. et al, (2025), Pilot and Feasibility Studies, 11
-
Accuracy of online surveys in predicting COVID-19 uptake and demand: A cohort study investigating vaccine sentiments and switching in 13 countries from 2020 to 2022.
Abel ZDV. et al, (2025), Vaccine, 62
-
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial
Zhou J. et al, (2025), EClinicalMedicine
-
Reducing inequalities through greater diversity in clinical trials - As important for medical devices as for drugs and therapeutics.
Roope LSJ. et al, (2025), Contemp Clin Trials Commun, 45
-
Quantifying the impact of intervention on health outcomes: A tool for assessing incremental changes to life expectancy.
Singh S. et al, (2025), Value Health